Brimonidine Tartrate 71921-0185-05
- Manufacturer
- Florida Pharmaceutical Products, Llc
- Dosage Form
- Solution/ Drops
- Route
- Ophthalmic
- Product Type
- Human Prescription Drug
- Marketing Start
- January 15, 2022
- Listing Expires
- December 31, 2027
- Application
- ANDA091691
Need to source Brimonidine Tartrate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brimonidine Tartrate | 2 mg/mg |
Drug Class
Adrenergic alpha-Agonists [MoA]alpha-Adrenergic Agonist [EPC]
Selected Package
71921-0185-05Selected5 mg in 1 BOTTLE, PLASTIC (71921-185-05)
Other packages for this product(2)
10 mg in 1 BOTTLE, PLASTIC (71921-185-10)
15 mg in 1 BOTTLE, PLASTIC (71921-185-15)